# FDA Inspection 810869 - RX South DBA RX3 Compounding Pharmacy LLC - December 14, 2012

Source: https://www.keypedia.com/records/fda_inspections/rx-south-dba-rx3-compounding-pharmacy-llc/4a4d58b7-7d11-46fc-be7b-15d83ab90763
Source feed: FDA_Inspections

> FDA Inspection 810869 for RX South DBA RX3 Compounding Pharmacy LLC on December 14, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 810869
- Company Name: RX South DBA RX3 Compounding Pharmacy LLC
- Inspection Date: 2012-12-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 865144 - 2014-02-21](https://www.keypedia.com/records/fda_inspections/rx-south-dba-rx3-compounding-pharmacy-llc/15db46cd-b310-45a0-a218-47d06d9a5b79)
- [FDA Inspection 865144 - 2014-02-21](https://www.keypedia.com/records/fda_inspections/rx-south-dba-rx3-compounding-pharmacy-llc/66cbcaf0-555c-4539-8aa2-b488424fa23c)

Company: https://www.keypedia.com/companies/rx-south-dba-rx3-compounding-pharmacy-llc/8f0ecc10-47c4-4fcc-8183-ff45b79eb24d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c